Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome.
Matsumoto S, Ueda T, Kakizaki H · Urology · 2013
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome.” is organized in H2HUBB under the research focus hydrogen water research study 2013 matsumoto. The publication is cited as Matsumoto S, Ueda T, Kakizaki H, Urology, 2013. This randomized controlled trial examined Effect of supplementation with hydrogen-rich water in patients with interstitial cystitis/painful bladder syndrome. The abstract describes Human participants; hydrogen delivered as hydrogen water; reported duration 8 weeks. The abstract reports: The results of the present study do not support the use of supplementation with hydrogen-rich water for treating patients with IC/PBS. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen water research study 2013 matsumoto overview
To investigate the efficacy of hydrogen-rich water for the treatment of patients with interstitial cystitis/painful bladder syndrome (IC/PBS). Because this is human clinical evidence, relevance depends on participant selection, controls, sample size, treatment duration, adherence, outcome measures, and replication.
Study design and hydrogen intervention
Publication type: Randomized controlled trial. Evidence type: Human clinical evidence. Research model or population: Human participants. Randomized: Yes. Blinding: Double-blind. Control status: Placebo-controlled.
Delivery method: Hydrogen water. Treatment duration: 8 weeks.
Reported findings and scientific interpretation
For this hydrogen water research study 2013 matsumoto, the study record reports the following: The abstract reports: The results of the present study do not support the use of supplementation with hydrogen-rich water for treating patients with IC/PBS.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.